Preferred Pharmaceuticals, Inc. recalls Artificial Tears Lubricant Eye Drops (glycerin 0.2%, hypromellose 0.2%, polyethylene glycol 400 1%), 0.5 oz bottles, Mfg:…
Lack of Assurance of Sterility
Read the official notice →- Date
- 2026-04-15
- Country
- United States
- Brand
- Preferred Pharmaceuticals
- Product
- Artificial Tears Lubricant Eye Drops (glycerin 0.2%, hypromellose 0.2%, polyethylene glycol 400 1%), 0.5 oz bottles, Mfg: Geri-Care;…
- Classification
- Class II
- Units
- Nationwide within the United States
- Category
- Drugs & medical
- Source
- FDA · Drug
Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer
What to do
- Check the product name, strength and lot number against the official notice.
- Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
- Ask the pharmacy or supplier about a replacement or refund.
General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.
More Preferred Pharmaceuticals recalls
- 2026-10-14
US- 2025-12-24
- US
Preferred Pharmaceuticals, Inc. recalls Ondansetron ODT Tablets, USP 4mg, 1x10 unit dose tablets, Mfg: Glenmark Pharmaceuticals Limited, Repackaged by Preferred…
Defective container: Preferred Pharmaceuticals received a letter from the manufacturer Glenmark, that the blister packs are not fully sealed and tablets falling out. Preferred Pharmaceuticals purchased the finished…
- 2025-05-07
- US
- 2024-09-04
- US
Preferred Pharmaceuticals, Inc. recalls Ibuprofen Tablets, USP 400mg, Generic for Motrin, Pkg Size: 30 tablets per bottle, Mfg: Dr. Reddy's Laboratories, Louisiana,…
Failed Impurities/Degradation Specifications - at 18-month Stability testing
- 2024-05-29
- US
Preferred Pharmaceuticals, Inc. recalls Duloxetine Delayed-Release Cap USP 30mg, 30-count bottle, Rx only, Preferred Pharmaceutcals, Inc., NDC 68788-9301-03
CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit
FDA · DrugPreferred Pharmaceuticals, Inc.Product distributed to CA, FL, OK, KS and CTOfficial notice → - 2023-07-12
- US
Other drugs & medical recalls in the United States
- 2026-04-15
- US
- US
- US
- US
Fagron Compounding Services recalls Vancomycin HCI, 1.5 grams added to 250 mL, 0.9% Sodium Chloride Injection USP, Fagron Sterile Services, 8710 34th St. N. Wichita, KS…
Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port
- US
- US
Cipla USA, Inc. recalls Lanreotide Injection, 120 mg/0.5 mL, Box contains 1 Pre-filled syringe, Single dose only, Rx Only, Manufactured by: Pharmathen…
Lack of Assurance of Sterility: Due to an FDA observation at the contract manufacturing site for deficiencies in their visual inspection procedure.